NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2024
CVR: 26270367
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 40,409 and a net result of DKK 67,346 compared with DKK 35,005 the year before. That is an increase of 425.7% compared with the year before. Equity in the 2024 report amounted to DKK 1,035,896. The solvency ratio was 97.9%.
- Gross Profit
- DKK 40,409
- Profit/Loss
- DKK 67,346
- Equity
- DKK 1,035,896
- Total Assets
- DKK 1,058,459
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 40K | 67K | 1M | - |
| 2023 | - | 8K | 35K | 969K | - |
| 2022 | - | 12K | 4K | 934K | 0 |
| 2021 | - | 16K | 8K | 930K | 0 |
| 2020 | - | -765K | -784K | 922K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NORDIC BIOTECH GENERAL PARTNER ApS has published its annual report for 2023. Gross profit came to DKK 7,687, and the net result was DKK 35,005.
About NORDIC BIOTECH GENERAL PARTNER ApS
NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.